{
    "title": "Long-awaited diet pill Contrave wins approval from the FDA for sale in the U.S.",
    "url": "https://www.dailymail.co.uk/femail/article-2751486/Long-awaited-diet-pill-gets-U-S-approval.html",
    "date": "2014-09-11",
    "keywords": [
        "obesity",
        "drug",
        "pill",
        "approval",
        "qsymia",
        "combination",
        "wednesday",
        "heart",
        "belviq",
        "market",
        "treatment",
        "orexigen",
        "contrave",
        "bupropion",
        "formulation",
        "naltrexone",
        "company",
        "analyst",
        "share",
        "health",
        "partner",
        "diet",
        "decade",
        "food",
        "administrationmade",
        "sale",
        "dependencethe",
        "fda",
        "june",
        "decision",
        "packagingbecause",
        "antidepressant",
        "warning",
        "risk",
        "battle",
        "choice",
        "marketing",
        "depression",
        "magic",
        "gaining",
        "stomach",
        "contraceptive",
        "injection",
        "article",
        "reimbursement",
        "government",
        "efficacy",
        "treatmentfor",
        "cent",
        "maintenance",
        "coverage",
        "daniel",
        "lang",
        "coportfolio",
        "manager",
        "rs",
        "value",
        "fund",
        "stake",
        "apathy",
        "conditionstill",
        "matthew",
        "co",
        "challenge",
        "future",
        "healthif",
        "cardiovascular",
        "europe",
        "america",
        "coit",
        "force",
        "cos",
        "loss",
        "ire",
        "side",
        "fenphen",
        "sas",
        "reason",
        "news",
        "conference",
        "call",
        "thursdaythe",
        "percent",
        "nasdaq"
    ],
    "category": [
        "femail"
    ]
}